Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January - June 2014
Strong Second Quarter
STOCKHOLM--(BUSINESS WIRE)--Regulatory News:
Moberg Pharma (STO:MOB):
FIRST SIX MONTHS (JAN-JUN 2014)
ยท Revenue MSEK 105.5 (83.4)
Help employers find you! Check out all the jobs and post your resume.